The value of model for end-stage liver disease and Child-Turcotte-Pugh scores over time in evaluating the prognosis of patients with decompensated cirrhosis: Experience in the Chinese mainland

Hepatology Research

Volumn 39, Issue 8, 2009, Pages 779-785

  Bie, Cai Qun ^a   Yang, Dong Hua ^a   Tang, Shao Hui ^a   Huang, Wei ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

CTP; MELD; Decompensated cirrhosis; Modified CTP; Prognosis analysis

Indexed keywords

ADEFOVIR DIPIVOXIL; ANTIBIOTIC AGENT; DIURETIC AGENT; LAMIVUDINE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASCITES; BACTERIAL INFECTION; BLEEDING; CHILD TURCOTTE PUGH SCORE; CHINESE; CLINICAL ASSESSMENT; DECOMPENSATED LIVER CIRRHOSIS; DISEASE MODEL; DISEASE SEVERITY; EDEMA; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATORENAL SYNDROME; HUMAN; INFECTION; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MELD SCORE; MORTALITY; NUTRITIONAL SUPPORT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 68349148128     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00514.x     Document Type: Article

References (23)

1. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.
2. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
3. Salerno F, Merli M, Cazzaniga M et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 36: 494-500.
4. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: A European study. Gut 2003; 52: 134-9.
5. Freeman RBJ, Wiesner RH, Harper A et al. The new liver allocation system: Moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 851-8.
6. Robert A, Chazouilleres O. Prothrombin time in liver failure: Time, ratio, activity percentage, or international normalized ratio? Hepatology 1996; 24: 1392-94.
7. Trotter JF, Brimhall B, Arjal R, Phillips C. Specific laboratory methodologies achieve higher Model for End-stage Liver Disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004; 10: 995-1000.
8. Cholongitas E, Marelli L, Kerry A et al. Different methods of creatinine measurement significantly affect MELD scores. Hepatology 2005; 42: 204A.
9. Arjal R, McAshland T, Smith D, Brimhall B, Trotter J. Variation in Model for End Liver Disease (MELD) score between transplant centres based on laboratory method for determination of international normalized ratio (INR). Hepatology 2005; 42: 205A.
10. Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003; 9: 12-18.
11. Huo T-I, Wu J-C, Lin H-C etal. Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced liver cirrhosis: Risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol 2005; 42: 826-32.
12. Huo TL, Lin HC, Wu JC et al. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl 2006; 12: 65-71.
13. Choi PC, Kim HJ, Choi WH etal. Model for end-stage liver disease model for end-stage liver disease -sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis. Liver Int 2009; 29: 221-6.
14. Schiff ER, Sorrell MF, Maddrey WC. Schiff's Diseases of the Liver, 8th edn. Philadelphia, PA and New York: Lippincott-Raven, 1999.
15. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis 1988; 8: 12-25.
16. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.
17. Zweig MH, Campbell G. Receiver operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39 (4): 561.
18. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology 2001; 33: 473-5.
19. Said A, Williams J, Holden J et al. Model for end-stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40: 897-903.
20. Amitrano L, Guardascione MA, Bennato R, Manguso F, Balzano A. MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol 2005; 42: 820-5.
21. Bambha K, Kim WR, Kremers WK et al. Predicting survival among patients listed for liver transplantation: An assessment of serial MELD measurements. Am J Transpl 2004; 4: 1798-804.
22. Kumashiro R, Sata M, Ishii K et al. Prognostic factors for short-term survival in alcoholic hepatitis in Japan: Analysis by logistic regression. Alcohol Clin Exp Res 1996; 20: 383A-386A.
23. Sheth M, Riggs M, Patel T. Utility of the Mayo end-stage liver disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002; 2: 2.